Myriad Genetics Research Shows Reduction in Hospitalizations for Patients with Depression after GeneSight Testing

Fewer patients were prescribed medications with gene-drug interactions after taking the GeneSight testSALT LAKE CITY, April 09, 2024 -- Myriad Genetics, Inc. , a leader in genetic testing and...

Related Keywords

United States ,American ,Glenn Farrell ,Dale Muzzey ,Priya Maheshwari ,Andrewa Nierenberg ,Devika Chawla ,Matt Scalo ,Hollyl Johnson ,Katie Johansen Taber ,Holly Johnson ,Alexander Gutin ,American Association Of Psychiatric Pharmacists ,Exchange Commission ,Nasdaq ,Genetics Inc ,Combinatorial Pharmacogenomic Testing ,Hospitalization Rates ,Real World Dataset ,Major Depressive ,American Association ,Psychiatric Pharmacists ,Genesight Psychotropic ,Myriad Genetics ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Current Reports ,Markets ,